IL-10 inhibits mature fibrotic granuloma formation during mycobacterium tuberculosis infection

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2778-2790

  Cyktor, Joshua C ^a   Carruthers, Bridget ^a   Kominsky, Rachel A ^a   Beamer, Gillian L ^a,b   Stromberg, Paul ^a   Turner, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CANCER INHIBITION; CELLULAR IMMUNITY; CONTROLLED STUDY; IN VIVO STUDY; LUNG GRANULOMA; LUNG TUBERCULOSIS; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TUMOR IMMUNITY;

ANIMALS; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; FIBROSIS; GRANULOMA, RESPIRATORY TRACT; INTERLEUKIN-10; LUNG; LYMPH NODES; MICE; MICE, INBRED C3H; MICE, INBRED CBA; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TUBERCULOSIS, PULMONARY;

EID: 84874882859     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202722     Document Type: Article

References (57)

1. World Health Organization. 2011. Global tuberculosis control: WHO report 2011. WHO Press, Geneva, Switzerland
2. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282: 677-686
3. Grosset, J. 2003. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob. Agents Chemother. 47: 833-836
4. Russell, D. G. 2007. Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5: 39-47
5. Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of mycobacterium tuberculosis. Annu. Rev. Microbiol. 55: 139-163
6. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Klein, A. T. Walker, and G. H. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320: 545-550
7. Flynn, J. L. 2006. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect. 8: 1179-1188
8. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma genedisrupted mice. J. Exp. Med. 178: 2243-2247
9. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254
10. Casanova, J. L., and L. Abel. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20: 581-620
11. Olobo, J. O., M. Geletu, A. Demissie, T. Eguale, K. Hiwot, G. Aderaye, and S. Britton. 2001. Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand. J. Immunol. 53: 85-91
12. Verbon, A., N. Juffermans, S. J. Van Deventer, P. Speelman, H. Van Deutekom, and T. Van Der Poll. 1999. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 115: 110-113
13. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61: 3482-3489
14. Bonecini-Almeida, M. G., J. L. Ho, N. Boéchat, R. C. Huard, S. Chitale, H. Doo, J. Geng, L. Rego, L. C. Lazzarini, A. L. Kritski, et al. 2004. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect. Immun. 72: 2628-2634
15. Turner, J., M. Gonzalez-Juarrero, D. L. Ellis, R. J. Basaraba, A. Kipnis, I. M. Orme, and A. M. Cooper. 2002. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 169: 6343-6351
16. Beamer, G. L., D. K. Flaherty, B. D. Assogba, P. Stromberg, M. Gonzalez- Juarrero, R. de Waal Malefyt, B. Vesosky, and J. Turner. 2008. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J. Immunol. 181: 5545-5550
17. Redford, P. S., A. Boonstra, S. Read, J. Pitt, C. Graham, E. Stavropoulos, G. J. Bancroft, and A. O'Garra. 2010. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 40: 2200-2210
18. Turner, J., M. Gonzalez-Juarrero, B. M. Saunders, J. V. Brooks, P. Marietta, D. L. Ellis, A. A. Frank, A. M. Cooper, and I. M. Orme. 2001. Immunological basis for reactivation of tuberculosis in mice. Infect. Immun. 69: 3264-3270
19. Vesosky, B., D. K. Flaherty, and J. Turner. 2006. Th1 cytokines facilitate CD8-Tcell- mediated early resistance to infection with Mycobacterium tuberculosis in old mice. Infect. Immun. 74: 3314-3324
20. Beamer, G. L., D. K. Flaherty, B. Vesosky, and J. Turner. 2008. Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice. Clin. Vaccine Immunol. 15: 474-483
21. Kang, D. D., Y. Lin, J. R. Moreno, T. D. Randall, and S. A. Khader. 2011. Profiling early lung immune responses in the mouse model of tuberculosis. PLoS ONE 6: e16161
22. Redford, P. S., P. J. Murray, and A. O'Garra. 2011. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4: 261-270
23. Kim, M. J., H. C. Wainwright, M. Locketz, L. G. Bekker, G. B. Walther, C. Dittrich, A. Visser, W. Wang, F. F. Hsu, U. Wiehart, L. Tsenova, et al. 2010. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2: 258-274
24. Ehlers, S., J. Benini, H. D. Held, C. Roeck, G. Alber, and S. Uhlig. 2001. Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J. Exp. Med. 194: 1847-1859
25. Schreiber, T., S. Ehlers, L. Heitmann, A. Rausch, J. Mages, P. J. Murray, R. Lang, and C. Hölscher. 2009. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 183: 1301-1312
26. Gallegos, A. M., E. G. Pamer, and M. S. Glickman. 2008. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J. Exp. Med. 205: 2359-2368
27. North, R. J. 1998. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 113: 55-58
28. Jung, Y. J., L. Ryan, R. LaCourse, and R. J. North. 2003. Increased interleukin- 10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology 109: 295-299
29. Roque, S., C. Nobrega, R. Appelberg, and M. Correia-Neves. 2007. IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J. Immunol. 178: 8028-8035
30. Beamer, G. L., and J. Turner. 2005. Murine models of susceptibility to tuberculosis. Arch. Immunol. Ther. Exp. (Warsz.) 53: 469-483
31. Carmeliet, P., Y. Dor, J. M. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, et al. 1998. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490
32. Araújo, A. P., T. F. Frezza, S. M. Allegretti, and S. Giorgio. 2010. Hypoxia, hypoxia-inducible factor-1a and vascular endothelial growth factor in a murine model of Schistosoma mansoni infection. Exp. Mol. Pathol. 89: 327-333
33. Reece, S. T., C. Loddenkemper, D. J. Askew, U. Zedler, S. Schommer-Leitner, M. Stein, F. A. Mir, A. Dorhoi, H. J. Mollenkopf, G. A. Silverman, and S. H. Kaufmann. 2010. Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice. J. Clin. Invest. 120: 3365-3376
34. Pichugin, A. V., B. S. Yan, A. Sloutsky, L. Kobzik, and I. Kramnik. 2009. Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am. J. Pathol. 174: 2190-2201
35. Cardona, P. J., S. Gordillo, J. Díaz, G. Tapia, I. Amat, A. Pallarés, C. Vilaplana, A. Ariza, and V. Ausina. 2003. Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 71: 5845-5854
36. Medina, E., and R. J. North. 1998. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93: 270-274
37. Medina, E., and R. J. North. 1999. Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination. Immunology 96: 16-21
38. Chackerian, A. A., and S. M. Behar. 2003. Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice. Tuberculosis (Edinb.) 83: 279-285
39. Apt, A. S., V. G. Avdienko, B. V. Nikonenko, I. B. Kramnik, A. M. Moroz, and E. Skamene. 1993. Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin. Exp. Immunol. 94: 322-329
40. Ulrichs, T., and S. H. Kaufmann. 2006. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208: 261-269
41. Russell, D. G., P. J. Cardona, M. J. Kim, S. Allain, and F. Altare. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10: 943-948
42. Fenton, M. J., M. W. Vermeulen, S. Kim, M. Burdick, R. M. Strieter, and H. Kornfeld. 1997. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65: 5149-5156
43. O'Leary, S., M. P. O'Sullivan, and J. Keane. 2011. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. Am. J. Respir. Cell Mol. Biol. 45: 172-180
44. Geijtenbeek, T. B., S. J. Van Vliet, E. A. Koppel, M. Sanchez-Hernandez, C. M. Vandenbroucke-Grauls, B. Appelmelk, and Y. Van Kooyk. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197: 7-17
45. Higgins, D. M., J. Sanchez-Campillo, A. G. Rosas-Taraco, E. J. Lee, I. M. Orme, and M. Gonzalez-Juarrero. 2009. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb.) 89: 149-157
46. Robinson, R. T., S. A. Khader, C. A. Martino, J. J. Fountain, M. Teixeira-Coelho, J. E. Pearl, S. T. Smiley, G. M. Winslow, D. L. Woodland, M. J. Walter, et al. 2010. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration. J. Exp. Med. 207: 591-605
47. Algood, H. M., P. L. Lin, and J. L. Flynn. 2005. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin. Infect. Dis. 41(Suppl. 3): S189-S193
48. Wolf, A. J., L. Desvignes, B. Linas, N. Banaiee, T. Tamura, K. Takatsu, and J. D. Ernst. 2008. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205: 105-115
49. Blomgran, R., and J. D. Ernst. 2011. Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J. Immunol. 186: 7110-7119
50. Sutherland, J. S., J. M. Young, K. L. Peterson, B. Sanneh, H. C. Whittle, S. L. Rowland-Jones, R. A. Adegbola, A. Jaye, and M. O. Ota. 2010. Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV- 1-infected patients before and after anti-retroviral treatment. J. Immunol. 184: 6537-6544
51. Duvall, M. G., M. L. Precopio, D. A. Ambrozak, A. Jaye, A. J. McMichael, H. C. Whittle, M. Roederer, S. L. Rowland-Jones, and R. A. Koup. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38: 350-363
52. Precopio, M. L., M. R. Betts, J. Parrino, D. A. Price, E. Gostick, D. R. Ambrozak, T. E. Asher, D. C. Douek, A. Harari, G. Pantaleo, et al. 2007. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204: 1405-1416
53. Wilkinson, K. A., and R. J. Wilkinson. 2010. Polyfunctional T cells in human tuberculosis. Eur. J. Immunol. 40: 2139-2142
54. Aagaard, C., T. T. Hoang, A. Izzo, R. Billeskov, J. Troudt, K. Arnett, A. Keyser, T. Elvang, P. Andersen, and J. Dietrich. 2009. Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One 4: e5930
55. Day, C. L., D. A. Abrahams, L. Lerumo, E. Janse van Rensburg, L. Stone, T. O'rie, B. Pienaar, M. de Kock, G. Kaplan, H. Mahomed, et al. 2011. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187: 2222-2232
56. Feng, C. G., D. Jankovic, M. Kullberg, A. Cheever, C. A. Scanga, S. Hieny, P. Caspar, G. S. Yap, and A. Sher. 2005. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J. Immunol. 174: 4185-4192
57. Pitt, J. M., E. Stavropoulos, P. S. Redford, A. M. Beebe, G. J. Bancroft, D. B. Young, and A. O'Garra. 2012. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-g and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J. Immunol. 189: 4079-4087